HWKN Stock Analysis: Hawkins | NASDAQ

Water Treatment, Specialty Ingredients, Industrial Chemicals, Custom Blending

Total Rating 44

Safety 81

Buy Signal -0.62

Specialty Chemicals
Industry Rotation: +5.2

Market Cap: 2.74B
Avg Turnover: 19.7M

Risk 3d forecast

Volatility39.7%

VaR 5^th Pctl6.67%

VaR vs Median1.93%

Reward TTM

Sharpe Ratio-0.73

Rel. Str. IBD5.8

Rel. Str. Peer Group20.6

Character TTM

Beta0.702

Beta Downside0.905

Hurst Exponent0.500

Drawdowns 3y

Max DD34.79%

CAGR/Max DD0.86

CAGR/Mean DD2.85

EPS (Earnings per Share)

EPS CAGR: 6.00%
EPS Trend: 71.6%

Last SUE: -0.30
Qual. Beats: 0

Revenue

Rev. CAGR: 7.51%
Rev. Trend: 94.7%

Last SUE: 0.22
Qual. Beats: 0

Warnings

Below Avwap Earnings

Below Sma 200d

Tailwinds

No distinct edge detected

Seasonality 11.6 years of data

Jan -1.7% 11

Feb -0.9% 2

Mar +0.1% 7

Apr -0.1% 7

May -1.1% 15

Jun -0.4% 8

Jul +7.2% 21

Aug +0.5% 16

Sep -2.6% 15

Oct -3.8% 16

Nov +3.7% 11

Dec +4.1% 15

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: HWKN Hawkins

Hawkins, Inc. (NASDAQ: HWKN) is a U.S.-based water treatment and specialty ingredients company headquartered in Roseville, Minnesota, operating through three segments: Water Treatment, Food and Health Sciences, and Industrial Solutions. The Water Treatment segment supplies chemicals, filtration equipment, and related services for potable, municipal, industrial, and agricultural water applications. The Food and Health Sciences segment distributes and formulates ingredients such as minerals, vitamins, sweeteners, enzymes, and pharmaceutical salts for nutrition, food, pharmaceutical, and agricultural customers. The Industrial Solutions segment provides bulk industrial chemicals-including acids, alkalis, and related products-to manufacturing, chemical processing, electronics, and surface finishing industries. In addition to distributing third-party chemicals, Hawkins repackages bulk industrial chemicals and performs custom blending, a value-added service that differentiates it from pure chemical manufacturers.

Founded in 1938 and listed on NASDAQ since 1993, Hawkins operates within the GICS Materials sector, specifically the Commodity Chemicals sub-industry. Its business model blends chemical distribution with specialty formulation and on-site water management services, generating revenue through both product sales and recurring service contracts with municipal and industrial clients.

Headlines to Watch Out For

Water Treatment segment drives margin expansion from infrastructure demand
Specialty chemical raw material costs pressure gross margins
Acquisition pipeline in food ingredients accelerates revenue growth

Piotroski VR-10 (Strict) 7.5

Net Income: 80.6m TTM > 0 and > 6% of Revenue
FCF/TA: 0.09 > 0.02 and ΔFCF/TA 0.91 > 1.0
NWC/Revenue: 12.58% < 20% (prev 14.38%; Δ -1.80% < -1%)
CFO/TA 0.15 > 3% & CFO 148.0m > Net Income 80.6m
Net Debt (269.4m) to EBITDA (174.9m): 1.54 < 3
Current Ratio: 2.27 > 1.5 & < 3
Outstanding Shares: last quarter (20.9m) vs 12m ago 0.21% < -2%
Gross Margin: 22.30% > 18% (prev 22.70%; Δ -0.40% > 0.5%)
Asset Turnover: 110.9% > 50% (prev 102.4%; Δ 8.53% > 0%)
Interest Coverage Ratio: 9.27 > 6 (EBIT TTM 120.7m / Interest Expense TTM 13.0m)

Altman Z'' 4.68

A: 0.14 (Total Current Assets 248.8m - Total Current Liabilities 109.6m) / Total Assets 1.01b
B: 0.52 (Retained Earnings 524.4m / Total Assets 1.01b)
C: 0.12 (EBIT TTM 120.7m / Avg Total Assets 997.3m)
D: 1.20 (Book Value of Equity 548.2m / Total Liabilities 458.0m)
Altman-Z'' = 4.68 = AA

Beneish M -3.26

DSRI: 0.99 (Receivables 151.8m/140.1m, Revenue 1.11b/1.01b)
GMI: 1.02 (GM 22.70% / 22.30%)
AQI: 0.50 (AQ_t 0.24 / AQ_t-1 0.48)
SGI: 1.09 (Revenue 1.11b / 1.01b)
TATA: -0.07 (NI 80.6m - CFO 148.0m) / TA 1.01b)
Beneish M = -3.26 (Cap -4..+1) = AA

What is the price of HWKN shares?

As of August 20, 2026, the stock is trading at USD 123.92 with a total of 127,216 shares traded. Over the past week, the price has changed by -4.14%, over one month by -14.58%, over three months by -18.76% and over the past year by -27.05%.

Current recommended Stop Loss: 117.40 (which is 5.3% or 1.3 ATR below the current price).

Is HWKN a buy, sell or hold?

Hawkins has received a consensus analysts rating of 4.00. Therefore, it is recommended to buy HWKN.

StrongBuy: 0
Buy: 2
Hold: 0
Sell: 0
StrongSell: 0

What are the forecasts/targets for the HWKN price?

Analysts Target Price	174.3	40.6%

Hawkins (HWKN) - Fundamental Data Overview as of 17 August 2026

Market Cap USD = 2.74b (2.74b USD * 1.0 USD.USD)
P/E Trailing = 33.9508
P/E Forward = 31.1526
P/S = 2.4733
P/B = 4.9967
P/EG = 2.5977
Revenue TTM = 1.11b USD
EBIT TTM = 120.7m USD
EBITDA TTM = 174.9m USD
Long Term Debt = 244.0m USD (from longTermDebt, last quarter)
Short Term Debt = 2.96m USD (from shortTermDebt, last quarter)
Debt = 277.3m USD (from shortLongTermDebtTotal, last quarter) + Leases 16.7m
Net Debt = 269.4m USD (calculated: Debt 277.3m - CCE 7.98m)
Enterprise Value = 3.01b USD (2.74b + Debt 277.3m - CCE 7.98m)
Interest Coverage Ratio = 9.27 (Ebit TTM 120.7m / Interest Expense TTM 13.0m)
EV/FCF = 32.77x (Enterprise Value 3.01b / FCF TTM 91.7m)
FCF Yield = 3.05% (FCF TTM 91.7m / Enterprise Value 3.01b)
FCF Margin = 8.29% (FCF TTM 91.7m / Revenue TTM 1.11b)
Net Margin = 7.29% (Net Income TTM 80.6m / Revenue TTM 1.11b)
Gross Margin = 22.30% ((Revenue TTM 1.11b - Cost of Revenue TTM 859.4m) / Revenue TTM)
Gross Margin QoQ = 23.44% (prev 20.40%)
Tobins Q-Ratio = 2.99 (Enterprise Value 3.01b / Total Assets 1.01b)
Interest Expense / Debt = 4.69% (Interest Expense 13.0m / Debt 277.3m)
Taxrate = 25.11% (27.0m / 107.7m)
NOPAT = 90.4m (EBIT 120.7m * (1 - 25.11%))
Current Ratio = 2.27 (Total Current Assets 248.8m / Total Current Liabilities 109.6m)
Debt / Equity = 0.51 (Debt 277.3m / totalStockholderEquity, last quarter 548.2m)
Debt / EBITDA = 1.54 (Net Debt 269.4m / EBITDA 174.9m)
Debt / FCF = 2.94 (Net Debt 269.4m / FCF TTM 91.7m)
Total Stockholder Equity = 527.0m (last 4 quarters mean from totalStockholderEquity)
RoA = 8.08% (Net Income 80.6m / Total Assets 1.01b)
RoE = 15.30% (Net Income TTM 80.6m / Total Stockholder Equity 527.0m)
RoCE = 15.65% (EBIT 120.7m / Capital Employed (Equity 527.0m + L.T.Debt 244.0m))
RoIC = 10.14% (NOPAT 90.4m / Invested Capital 891.6m)
WACC = 8.00% (E(2.74b)/V(3.01b) * Re(8.45%) + D(277.3m)/V(3.01b) * Rd(4.69%) * (1-Tc(0.25)))
Discount Rate = 8.45% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: -62.56 | Cagr: -0.16%
[DCF] Terminal Value 77.69% ; FCFF base≈87.4m ; Y1≈98.7m ; Y5≈139.5m
[DCF] Fair Price = 88.06 (EV 2.11b - Net Debt 269.4m = Equity 1.84b / Shares 20.9m; r=8.35% [WACC [floored]]; 5y FCF grow 13.18% → 2.50% )
EPS Correlation: 71.60 | EPS CAGR: 6.00% | SUE: -0.30 | # QB: 0
Revenue Correlation: 94.70 | Revenue CAGR: 7.51% | SUE: 0.22 | # QB: 0
EPS current Quarter (2026-09-30): EPS=1.35 | Chg30d=-0.73% | Revisions=+0% | Analysts=2
EPS next Quarter (2026-12-31): EPS=0.83 | Chg30d=-10.22% | Revisions=-40% | Analysts=2
EPS current Year (2027-03-31): EPS=4.59 | Chg30d=-4.57% | Revisions=-40% | GrowthEPS=+16.2% | GrowthRev=+8.2%
EPS next Year (2028-03-31): EPS=5.09 | Chg30d=-5.65% | Revisions=-40% | GrowthEPS=+10.8% | GrowthRev=+6.4%
[Analyst] Revisions Ratio: -55% (up=1, down=7)